126-50-1 Usage
General Description
4-acetyl-4-(2-cyanoethyl)heptanedinitrile is a chemical compound that consists of a heptanedinitrile backbone with an acetyl group and a cyanoethyl group attached to it. It is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and organic compounds. 4-acetyl-4-(2-cyanoethyl)heptanedinitrile is known for its high reactivity and is often used in organic synthesis due to its ability to undergo various chemical reactions to produce a wide range of useful products. Its versatile nature and stability make it a valuable component in the field of chemical synthesis and research.
Check Digit Verification of cas no
The CAS Registry Mumber 126-50-1 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,2 and 6 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 126-50:
(5*1)+(4*2)+(3*6)+(2*5)+(1*0)=41
41 % 10 = 1
So 126-50-1 is a valid CAS Registry Number.
InChI:InChI=1/C12H15N3O/c1-11(16)12(5-2-8-13,6-3-9-14)7-4-10-15/h2-7H2,1H3
126-50-1Relevant articles and documents
COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS
-
Page/Page column 96, (2014/03/25)
The present disclosure is directed to compounds and methods for the treatment of disorders associated with fluid retention or salt overload, such as heart failure (in particular, congestive heart failure), chronic kidney disease, end-stage renal disease, liver disease, and peroxisome proliferator-activated receptor (PPAR) gamma agonist- induced fluid retention. The present disclosure is also directed to compounds and methods for the treatment of hypertension. The present disclosure is also directed to compounds and methods for the treatment of gastrointestinal tract disorders, including the treatment or reduction of pain associated with gastrointestinal tract disorders.
